Patricia S. Campbell

Person

Palo Alto, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Formulations for the administration of fluoxetine
- Patent number 7,011,844
- Issue date Mar 14, 2006
- Alza Corporation
- Robert M. Gale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations for transdermal delivery of pergolide
- Patent number 6,572,879
- Issue date Jun 3, 2003
- ALZA Corporation
- Su Il Yum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations for the administration of fluoxetine
- Patent number 6,512,010
- Issue date Jan 28, 2003
- Alza Corporation
- Robert M. Gale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Reduction of skin irritation during electrotransport delivery
- Patent number 6,324,424
- Issue date Nov 27, 2001
- Alza Corporation
- Philip W. Ledger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Drug delivery devices and process of manufacture
- Patent number 6,174,545
- Issue date Jan 16, 2001
- Alza Corporation
- David J. Enscore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Drug delivery devices and process of manufacture
- Patent number 6,007,837
- Issue date Dec 28, 1999
- Alza Corporation
- David J. Enscore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations for transdermal delivery of pergolide
- Patent number 6,001,390
- Issue date Dec 14, 1999
- ALZA Corporation
- Su I Yum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition and method of enhancing electrotransport agent delivery
- Patent number 5,990,179
- Issue date Nov 23, 1999
- ALZA Corporation
- J. Richard Gyory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition and method of enhancing electrotransport agent delivery
- Patent number 5,985,316
- Issue date Nov 16, 1999
- ALZA Corporation
- J. Richard Gyory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Reduction of skin irritation during electrotransport delivery
- Patent number 5,865,792
- Issue date Feb 2, 1999
- ALZA Corporation
- Philip W. Ledger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transdermal drug delivery device having enhanced adhesion
- Patent number 5,840,327
- Issue date Nov 24, 1998
- ALZA Corporation
- Robert M. Gale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Reduction of skin irritation during electrotransport delivery
- Patent number 5,693,010
- Issue date Dec 2, 1997
- ALZA Corporation
- Philip W. Ledger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral sustained release drug delivery device
- Patent number 5,512,293
- Issue date Apr 30, 1996
- ALZA Corporation
- Felix A. Landrau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Subsaturated transdermal therapeutic system having improved release...
- Patent number 5,462,745
- Issue date Oct 31, 1995
- ALZA Corporation
- David J. Enscore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Subsaturated transdermal therapeutic system having improved release...
- Patent number 5,344,656
- Issue date Sep 6, 1994
- ALZA Corporation
- David J. Enscore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Subsaturated transdermal therapeutic system having improved release...
- Patent number 5,342,623
- Issue date Aug 30, 1994
- ALZA Corporation
- David J. Enscore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Subsaturated transdermal therapeutic system having improved release...
- Patent number 4,908,027
- Issue date Mar 13, 1990
- ALZA Corporation
- David J. Enscore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transdermal drug delivery device
- Patent number 4,867,982
- Issue date Sep 19, 1989
- ALZA Corporation
- Patricia S. Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for preventing the formation of a crystalline hydrate in a d...
- Patent number 4,832,953
- Issue date May 23, 1989
- ALZA Corporation
- Patricia S. Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transdermal contraceptive formulations
- Patent number 4,816,258
- Issue date Mar 28, 1989
- ALZA Corporation
- Diane E. Nedberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transdermal drug delivery device
- Patent number 4,725,439
- Issue date Feb 16, 1988
- ALZA Corporation
- Patricia S. Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transdermal therapeutic system having improved delivery characteris...
- Patent number 4,704,282
- Issue date Nov 3, 1987
- ALZA Corporation
- Patricia S. Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Percutaneous absorption enhancer dispenser for use in coadministeri...
- Patent number 4,460,372
- Issue date Jul 17, 1984
- ALZA Corporation
- Patricia S. Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosage for coadministering drug and percutaneous absorption enhancer
- Patent number 4,379,454
- Issue date Apr 12, 1983
- ALZA Corporation
- Patricia S. Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Novel formulations for the administration of fluoxetine
- Publication number 20050186277
- Publication date Aug 25, 2005
- Robert M. Gale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel formulations for transdermal delivery of pergolide
- Publication number 20040209909
- Publication date Oct 21, 2004
- Su Il Yum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel formulations for the administration of fluoxetine
- Publication number 20030166624
- Publication date Sep 4, 2003
- Robert M. Gale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patricia S. Campbell

Person

Patents Grantslast 30 patents

Formulations for the administration of fluoxetine

Formulations for transdermal delivery of pergolide

Formulations for the administration of fluoxetine

Reduction of skin irritation during electrotransport delivery

Drug delivery devices and process of manufacture

Drug delivery devices and process of manufacture

Formulations for transdermal delivery of pergolide

Composition and method of enhancing electrotransport agent delivery

Composition and method of enhancing electrotransport agent delivery

Reduction of skin irritation during electrotransport delivery

Transdermal drug delivery device having enhanced adhesion

Reduction of skin irritation during electrotransport delivery

Oral sustained release drug delivery device

Subsaturated transdermal therapeutic system having improved release...

Subsaturated transdermal therapeutic system having improved release...

Subsaturated transdermal therapeutic system having improved release...

Subsaturated transdermal therapeutic system having improved release...

Transdermal drug delivery device

Method for preventing the formation of a crystalline hydrate in a d...

Transdermal contraceptive formulations

Transdermal drug delivery device

Transdermal therapeutic system having improved delivery characteris...

Percutaneous absorption enhancer dispenser for use in coadministeri...

Dosage for coadministering drug and percutaneous absorption enhancer

Patents Applicationslast 30 patents

Novel formulations for the administration of fluoxetine

Novel formulations for transdermal delivery of pergolide

Novel formulations for the administration of fluoxetine